TNIP1 and endothelial dysfunction: The induction of chronic inflammation, endothelial dysfunction, and cardiac hypertrophy by a single protein malformation highlights the need for selective therapeutic targets of inflammation to limit multiorgan disease, and the ABIN1 pathway might be one potential therapeutic target.